0 results for 'Genentech'
Defendants moved to transfer venue to the District of Delaware.
Petitioners sought a writ of mandamus to challenge the district court's decision to transfer their suit against the Commodities Futures Trading Commission to the District of Columbia, arguing the transfer was an abuse of discretion.
Anti-VEGF Medications in Vials, Pre-Filled Syringes Compete in Different Product Markets
In a dispute over a piece of real property being developed into a subdivision, appellees, Lester J. Strait, and intervenors Kenneth and Shannon Taylor, sued appellants, the developers, claiming title to the Torian Lane Strip, an undeveloped portion of the land and an easement across it.
Hanover Had Duty to Insure Company as Additional Insured From Feb. 2020 to Sept. 2, 2021
View more book results for the query "Genentech"
Treatment of Antibody Claims In the U.S. After 'Amgen v. Sanofi'
The future of antibody claiming in the United States is uncertain following the U.S. Supreme Court's ruling in 'Amgen Inc. v. Sanofi,' a highly anticipated decision concerning enablement and whether the traditional way to claim antibodies — claiming antibodies by their function — will survive as a valid claiming strategy.Amid 'Brutal Competition' and Demand in Patent Practices, Orrick Grows IP Group
Arnold & Porter, Crowell & Moring, McCarter & English, and Miles & Stockbridge also picked up D.C. partners in their key practices this past week.Seeking In-House Perspectives on Litigation
Last year in-house litigators from five companies shared lessons learned from their professional journeys and insights about hiring decisions. We want to hear from more of them.Challenge to State's 'Assault Weapons Ban' Survives Motion to Dismiss Suit
Pharmaceutical Legal and Regulatory Trends To Watch in 2024
This article highlights several notable legal and regulatory developments in 2023 and discusses developments that will continue to shape the pharmaceutical industry in 2024.